全文获取类型
收费全文 | 4935篇 |
免费 | 276篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 87篇 |
儿科学 | 267篇 |
妇产科学 | 49篇 |
基础医学 | 487篇 |
口腔科学 | 80篇 |
临床医学 | 361篇 |
内科学 | 1056篇 |
皮肤病学 | 85篇 |
神经病学 | 355篇 |
特种医学 | 147篇 |
外科学 | 591篇 |
综合类 | 83篇 |
一般理论 | 2篇 |
预防医学 | 271篇 |
眼科学 | 449篇 |
药学 | 466篇 |
中国医学 | 24篇 |
肿瘤学 | 378篇 |
出版年
2023年 | 37篇 |
2022年 | 84篇 |
2021年 | 183篇 |
2020年 | 100篇 |
2019年 | 137篇 |
2018年 | 170篇 |
2017年 | 113篇 |
2016年 | 159篇 |
2015年 | 161篇 |
2014年 | 230篇 |
2013年 | 290篇 |
2012年 | 410篇 |
2011年 | 356篇 |
2010年 | 200篇 |
2009年 | 187篇 |
2008年 | 294篇 |
2007年 | 333篇 |
2006年 | 300篇 |
2005年 | 225篇 |
2004年 | 236篇 |
2003年 | 209篇 |
2002年 | 174篇 |
2001年 | 49篇 |
2000年 | 64篇 |
1999年 | 55篇 |
1998年 | 23篇 |
1997年 | 30篇 |
1996年 | 29篇 |
1995年 | 20篇 |
1994年 | 15篇 |
1993年 | 19篇 |
1992年 | 44篇 |
1991年 | 27篇 |
1990年 | 25篇 |
1989年 | 21篇 |
1988年 | 21篇 |
1987年 | 16篇 |
1986年 | 16篇 |
1985年 | 17篇 |
1984年 | 14篇 |
1983年 | 14篇 |
1982年 | 12篇 |
1981年 | 8篇 |
1980年 | 12篇 |
1979年 | 9篇 |
1975年 | 9篇 |
1974年 | 7篇 |
1972年 | 12篇 |
1971年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有5238条查询结果,搜索用时 328 毫秒
1.
Kow Chia Siang Ramachandram Dinesh Sangarran Hasan Syed Shahzad 《Journal of thrombosis and thrombolysis》2022,54(2):217-218
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
Dinesh Singhal Nandini Vasdev Arvinder Soin Subash Gupta Samiran Nundy 《Indian journal of gastroenterology》2006,25(4):206-207
It is difficult to distinguish between carcinoid tumors of the pancreatic head and periampullary region and carcinomas preoperatively. Between 1996 and 2002, 125 consecutive pancreaticoduodenectomies done by us for periampullary tumors (14 carcinoids, 111 carcinomas) were analyzed. Patients with carcinoid tumors had significantly younger mean age (48 vs. 54 years), longer history (32 vs. 8 weeks), lower serum total bilirubin levels (1.4 vs. 6.3 mg/dL) and on CT scan, had larger, well-localized tumors (5 cm vs. 2 cm). Their postoperative course was better with no mortality or major morbidity, whereas after resection for carcinoma 7 (6.3%) patients died and 30 (27%) had major postoperative complications. Thus, a tumor of this region in a young patient with indolent history, low bilirubin level and with CT scan depicting a large expansile lesion suggests a carcinoid. Such tumors may be safely resected with low postoperative morbidity and mortality and good long-term prognosis. 相似文献
4.
Dr. Menon Raj Gopal M.Ch. AlDelamie Taha FRCS Valliathu John FRCS Zacharias Sunny FRCS Lawati Al Adil FRCS Venkatraman M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(3):173-177
Background Despite improving surgical techniques, treatment of heart valve disease in children remains controversial. Somatic growth
and adequate anticoagulation are of concern when children undergo valve replacement. We conducted this study to evaluate the
performance of valves in this age group.
Methods 42 children under the age of 13 years who underwent valve replacement were included in this study. Totally, 50 valves were
implanted in 42 patients: 48 were mechanical prostheses, two were bioprosthetic both in pulmonary position. 37 (74%) valves
were implanted in mitral position, 10 (20%) in aortic position, 1 (2%) in tricuspid position and 2 (4%) in pulmonary position.
Preoperatively, 14 (33,3%) patients were in New York Heart Association (NYHA) class IV, while 27 (64.2%) were in NYHA class
III.
Results There were 2 (4.7%) hospital deaths and 2 (4.7%) late deaths while 2 (4.7%) patients were lost to follow up. The mean follow
up period was 9.4 yrs. 35 (83.3%) patients are in NYHA Class I and free of all medications except warfarin. 3 (7.1%) patients
have undergone 5 successful pregnancies. The median INR was 2.23. Major thrombo-embolic episode occurred in 1 (2.3%) patient.
Conclusions In view of the problems of sizing, anticoagulation and need for re-operation at an early age, there is a reluctance to replace
valves in children. This study shows that despite these problems, valve replacement can be undertaken safely and successfully
in children, when repair has failed or not technically feasible. 相似文献
5.
Dinesh Rakheja Payal Kapur Mai P. Hoang Lonnie C. Roy Michael J. Bennett 《Medical hypotheses》2005,65(6):681
Mammalian fatty acid synthase (FASE) overexpression has been shown in a number of human malignancies including colonic adenocarcinoma. Since FASE synthesizes only saturated fatty acids, we hypothesized that cancer cells have a greater proportion of long-chain saturated fatty acids. We studied and found an unequivocal increase in saturated C18 fatty acid (stearic acid) in colonic adenocarcinoma compared to adjacent normal colonic mucosa. The increase is even more striking when measured as a ratio of stearic acid to the unsaturated C18 fatty acids (oleic acid and linoleic acid). This change in fatty acid composition of the cancer cells should significantly alter their physical and biological properties. The increase in relative proportion of saturated fatty acids should make the cancer cells more susceptible to cryodamage and measurement of fatty acid composition of cancer cells may help individualize the temperature for cryotherapy. Also, the lipid alterations may affect the structure and functions of lipid rafts, which may enable the cancer cells to affect signaling mechanisms such as those involved in cell growth and apoptosis. Dietary or therapeutic interventions targeting lipid rafts may thus be an option for cancer treatment. 相似文献
6.
Exacerbation of Partial Seizures and Onset of Nonepileptic Myoclonus with Carbamazepine 总被引:4,自引:3,他引:1
A child had two to three generalized tonic-clonic (GTC) seizures per week unresponsive to phenobarbital (PB) and valproate (VPA). Interictal EEG demonstrated left occipital spikes. When carbamazepine (CBZ) therapy was started, he developed very frequent (4-6/day) complex partial seizures (CPS) characterized on ictal EEG by focal right temporal lobe discharges. The seizure exacerbation, which was associated with development of nonepileptic, multifocal myoclonus, resolved 24 h after CBZ was discontinued. The exacerbation occurred with therapeutic CBZ serum levels, but may have been related to the toxic levels of carbamazepine-10, 11-epoxide (CBZE). 相似文献
7.
Joseph G Rajendran Darrell R Fisher Ajay K Gopal Lawrence D Durack Oliver W Press Janet F Eary 《Journal of nuclear medicine》2004,45(6):1059-1064
Radioimmunotherapy (RIT) using (131)I-tositumomab has been used successfully to treat relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL). Our approach to treatment planning has been to determine limits on radiation absorbed dose to critical nonhematopoietic organs. This study demonstrates the feasibility of using CT to adjust for actual organ volumes in calculating organ-specific absorbed dose estimates. METHODS: Records of 84 patients who underwent biodistribution studies after a trace-labeled infusion of (131)I-tositumomab for RIT (January 1990 and April 2003) were reviewed. Serial planar gamma-camera images and whole-body NaI probe counts were obtained to estimate (131)I-antibody source-organ residence times as recommended by the MIRD Committee. The source-organ residence times for standard man or woman were adjusted by the ratio of the MIRD phantom organ mass to the CT-derived organ mass. RESULTS: The mean radiation absorbed doses (in mGy/MBq) for our data using the MIRD model were lungs = 1.67; liver = 1.03; kidneys = 1.08; spleen = 2.67; and whole body = 0.3; and for CT volume-adjusted organ volumes (in mGy/MBq) were lungs = 1.30; liver = 0.92; kidneys = 0.76; spleen = 1.40; and whole body = 0.22. We determined the following correlation coefficients between the 2 methods for the various organs: lungs, 0.49 (P = 0.0001); liver, 0.64 (P = 0.004); kidneys, 0.45 (P = 0.0004); spleen, 0.22 (P = 0.0001); and whole body, 0.78 (P = 0.0001), for the residence times. For therapy, patients received mean (131)I administered activities of 19.2 GBq (520 mCi) after adjustment for CT-derived organ mass compared with 16.0 GBq (433 mCi) that would otherwise have been given had therapy been based only using standard MIRD organ volumes-a statistically significant difference (P = 0.0001). CONCLUSION: We observed large variations in organ masses among our patients. Our treatments were planned to deliver the maximally tolerated radiation dose to the dose-limiting normal organ. This work provides a simplified method for calculating patient-specific radiation doses by adjusting for the actual organ mass and shows the value of this approach in treatment planning for RIT. 相似文献
8.
Dinesh Paul 《Indian journal of pediatrics》1989,56(1):4-5
On September 7-8, 1988, health professionals attended a national seminar at the National Institute of Public Cooperation and Child Development in New Delhi to review policies of each government department in India that dispenses essential drugs to PHC workers. Another objective included the need to agree on what essential drugs should be distributed by the various types of PHC workers. The consensus of the group was that the different levels of health services and competence of the PHC workers should determine the basic list of PHC essential drugs. In addition, the morbidity pattern in the community, safety, effectiveness, and cost of the drugs must also determine which drugs are essential. Anganwadi workers/village health guides should all have a kit with 17 of the 75 essential drugs, such as vitamin A solution, oral rehydration solution packets, choloroquine, and chlorine tablets. In addition to the same 17 drugs, all subcenters should have in stock aspirin, metoclopramide, oral contraceptives, methergin in both tablet and injection form, and activated charcoal. Each PHC center should have all of the above and the remaining 53 drugs which include antibiotics, bronchodialators, eye drops, injections, vaccines (e.g., DPT and BCG), ointments, antileprosy drugs, and snake venom. The quantity of each drug should be based on the morbidity pattern, seasonal trend, and sickness load of the area. All PHC workers should attend inservice training where tested and effective training modules and charts in each local language are used to learn how to judiciously prescribe these drugs. Further, this essential drug program should be continuously monitored and evaluated. 相似文献
9.
Joseph G Rajendran Ajay K Gopal Darrel R Fisher Larry D Durack Ted A Gooley Oliver W Press 《Journal of nuclear medicine》2008,49(5):837-844
Myeloablative radioimmunotherapy using (131)I-tositumomab (anti-CD20) monoclonal antibodies is an effective therapy for B-cell non-Hodgkin's lymphoma. The amount of radioactivity for radioimmunotherapy may be determined by several methods, including those based on whole-body retention and on dose to a limiting normal organ. The goal of each approach is to deliver maximal myeloablative amounts of radioactivity within the tolerance of critical normal organs. METHODS: Records of 100 consecutive patients who underwent biodistribution and dosimetry evaluation after tracer infusion of (131)I-tositumomab before radioimmunotherapy were reviewed. We assessed organ and tissue activities over time by serial gamma-camera imaging to calculate radiation-absorbed doses. Organ volumes were determined from CT scans for organ-specific dosimetry. These dose estimates helped us to determine therapy on the basis of projected dose to the critical normal organ receiving a maximum tolerable radiation dose. We compared organ-specific dosimetry for treatment planning with the whole-body dose-assessment method by retrospectively analyzing the differences in projected organ-absorbed doses and their ratios. RESULTS: Mean organ doses per unit of administered activity (mGy/MBq) estimated by both methods were 0.33 for liver and 0.33 for lungs by the whole-body method and 1.52 for liver and 1.74 for lungs by the organ-specific method (P=0.0001). The median differences between methods were 0.92 mGy/MBq (range, 0.36-2.2 mGy/MBq) for lungs, 0.82 mGy/MBq (range, 0.28-1.67 mGy/MBq) for liver, and -0.01 mGy/MBq (range, -0.18-0.16 mGy/MBq) for whole body. The median ratios of the treatment activities based on limiting normal-organ dose were 5.12 (range, 2.33-10.01) for lungs, 4.14 (range, 2.16-6.67) for liver, and 0.94 (range, 0.79-1.22) for whole body. We found substantial differences between the dose estimated by the 2 methods for liver and lungs (P=0.0001). CONCLUSION: Dosimetry based on whole-body retention will underestimate the organ doses, and a preferable approach is to evaluate organ-specific doses by accounting for actual radionuclide biodistribution. Myeloablative treatments based on the latter approach allow administration of the maximum amount of radioactivity while minimizing toxicity. 相似文献
10.